Skip to content

S&P 500 Executive Compensation

Search and browse compensation for S&P 500 named executive officers.

Catalog as of September 15, 2026. Not a live market feed.

48 companies

3M

3M Company

MMM · NYSE

William M. Brown

Chairman And Chief Executive Officer

$21M

FY 2025 reported total

View company →

Abbott

Abbott Laboratories

ABT · NYSE

Robert B. Ford

Chairman Of The Board And Chief Executive Officer

$24.2M

FY 2025 reported total

View company →

AbbVie

AbbVie Inc.

ABBV · NYSE

Robert A. Michael

Chairman Of The Board And Chief Executive Officer

$32.5M

FY 2025 reported total

View company →

Align Technology

Align Technology Inc

ALGN · NASDAQ

Joseph M. Hogan

President And Chief Executive Officer

$19.2M

FY 2025 reported total

View company →

Amgen

Amgen Inc.

AMGN · NASDAQ

Robert A. Bradway

Chief Executive Officer And President

$24.7M

FY 2025 reported total

View company →

Baxter International

Baxter International Inc

BAX · NYSE

Andrew Hider

President and CEO

$29.8M

FY 2025 reported total

View company →

BD

Becton, Dickinson and Company

BDX · NYSE

Thomas E. Polen

Chairman, Chief Executive Officer And President

$17.1M

FY 2025 reported total

View company →

Bio-Techne

Bio-Techne Corp

TECH · NASDAQ

Kim Kelderman

President and CEO

$8.2M

FY 2025 reported total

View company →

Biogen

Biogen Inc.

BIIB · NASDAQ

Christopher A. Viehbacher

President And Chief Executive Officer

$23.6M

FY 2025 reported total

View company →

Boston Scientific

Boston Scientific Corporation

BSX · NYSE

Michael F. Mahoney

Chairman Of The Board, President And Chief Executive Officer

$23.5M

FY 2025 reported total

View company →

Bristol Myers Squibb

Bristol-Myers Squibb Company

BMY · NYSE

Christopher S. Boerner

Ph.d.board Chair And Chief Executive Officer

$21.9M

FY 2025 reported total

View company →

Centene

Centene Corp

CNC · NYSE

Sarah M. London

Chief Executive Officer

$19.5M

FY 2025 reported total

View company →

Charles River Laboratories International

Charles River Laboratories International, Inc.

CRL · NYSE

James C. Foster

Chair, President, Chief Executive Officer And Director

$15.4M

FY 2025 reported total

View company →

Davita

Davita Inc.

DVA · NYSE

Javier J. Rodriguez

Chief Executive Officer

$18.2M

FY 2025 reported total

View company →

Dexcom

Dexcom Inc

DXCM · NASDAQ

Jacob Leach

President & Chief Executive Officer

$8M

FY 2025 reported total

View company →

Edwards Lifesciences

Edwards Lifesciences Corp

EW · NYSE

Mr. Zovighian

Chief Executive Officer And Director

$17.5M

FY 2025 reported total

View company →

Elevance Health

Elevance Health, Inc.

ELV · NYSE

Gail Boudreaux

President And Chief Executive Officer (ceo)

$22.6M

FY 2025 reported total

View company →

Eli Lilly

Eli Lilly and Company

LLY · NYSE

David A. Ricks

Chair, President, And Chief Executive Officer

$36.7M

FY 2025 reported total

View company →

GE HealthCare Technologies

GE HealthCare Technologies Inc.

GEHC · NASDAQ

Peter J. Arduini

President and CEO

$18.6M

FY 2025 reported total

View company →

Gilead

Gilead Sciences, Inc.

GILD · NASDAQ

Daniel P. O’Day

Chairman And Chief Executive Officer

$28.4M

FY 2025 reported total

View company →

HCA Healthcare

HCA Healthcare, Inc.

HCA · NYSE

Samuel N. Hazen

Chief Executive Officer

$26.5M

FY 2025 reported total

View company →

Henry Schein

Henry Schein Inc

HSIC · NASDAQ

No current CEO in this filing

Named officers listed on the company page

FY 2025 DEF 14A

View company →

Humana

Humana Inc.

HUM · NYSE

James A. Rechtin

President And Chief Executive Officer

$18.8M

FY 2025 reported total

View company →

Idexx Laboratories

Idexx Laboratories Inc

IDXX · NASDAQ

Jonathan J. Mazelsky

President And Chief Executive Officer

$14.6M

FY 2025 reported total

View company →